Oppenheimer Analyst Recommendations & Stock Picks (NYSE:OPY)

Name: Community Performance Rating
Item: Oppenheimer
Rating: 3.1
Author: MarketBeat

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Oppenheimer. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Oppenheimer.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
AMRC Ameresco	$18.61 -4.3%	4/17/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Ameresco (NYSE:AMRC) on 4/17/2024
BLZE Backblaze	$9.12 +0.1%	4/17/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$11.00 -> $13.00	Low	View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 4/17/2024
BAC Bank of America	$35.22 +1.6%	4/17/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$46.00 -> $45.00	Low	View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/17/2024
FSLR First Solar	$178.01 +2.8%	4/17/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$269.00	Low	View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 4/17/2024
MS Morgan Stanley	$90.08 +1.1%	4/17/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$97.00 -> $101.00	Low	View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/17/2024
PANW Palo Alto Networks	$277.33 +0.8%	4/17/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$305.00 -> $330.00	Low	View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
QMCO Quantum	$0.41	4/17/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Quantum (NASDAQ:QMCO) on 4/17/2024
TWLO Twilio	$58.73 -0.7%	4/17/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$75.00	Low	View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 4/17/2024
VIRX Viracta Therapeutics	$0.94 +32.3%	4/17/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$13.00	Low	View details for Oppenheimer rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/17/2024
OBDE Blue Owl Capital Co. III	$15.07 -0.2%	4/17/2024	Initiated by	Oppenheimer	-	Outperform	$16.00	Low	View details for Oppenheimer rating of Blue Owl Capital Co. III (NYSE:OBDE) on 4/17/2024
SKIL Skillsoft	$5.78 +6.1%	4/16/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 4/16/2024
AGCO AGCO	$116.24 -0.7%	4/16/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$153.00 -> $154.00	Low	View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 4/16/2024
CNHI CNH Industrial	$12.35 -1.6%	4/16/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of CNH Industrial (NYSE:CNHI) on 4/16/2024
CTVA Corteva	$53.53 +0.4%	4/16/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$62.00 -> $67.00	Low	View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 4/16/2024
GS The Goldman Sachs Group	$403.91 +1.8%	4/16/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$446.00 -> $479.00	Low	View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/16/2024
AVTX Avalo Therapeutics	$13.62 -14.6%	4/16/2024	Upgraded by	Oppenheimer	-	Market Perform -> Outperform		Low	View details for Oppenheimer rating of Avalo Therapeutics (NASDAQ:AVTX) on 4/16/2024
C Citigroup	$58.17 +2.0%	4/15/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$88.00 -> $87.00	Low	View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/15/2024
EL Estée Lauder Companies	$138.07 +0.8%	4/15/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Estée Lauder Companies (NYSE:EL) on 4/15/2024
JPM JPMorgan Chase & Co.	$179.96 -0.5%	4/15/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$219.00 -> $217.00	Low	View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 4/15/2024
VRTX Vertex Pharmaceuticals	$393.10 -0.3%	4/15/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$500.00	Low	View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/15/2024
VERU Veru	$1.16 -7.2%	4/15/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$7.00 -> $5.00	Low	View details for Oppenheimer rating of Veru (NASDAQ:VERU) on 4/15/2024
WFC Wells Fargo & Company	$57.18 +1.4%	4/15/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 4/15/2024
ZWS Zurn Elkay Water Solutions	$31.25 -1.5%	4/12/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$36.00 -> $37.00	Low	View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 4/12/2024
RVMD Revolution Medicines	$36.82 +1.6%	4/12/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$43.00 -> $45.00	Low	View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 4/12/2024
SKYE Skye Bioscience	$17.36 +6.8%	4/12/2024	Initiated by	Oppenheimer	-	Outperform	$25.00	Low	View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024
SKYE Skye Bioscience	$17.36 +6.8%	4/12/2024	Initiated by	Oppenheimer	-	Outperform	$25.00	Low	View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024
QTTB Q32 Bio	$24.12 -3.5%	4/11/2024	Initiated by	Oppenheimer	-	Outperform	$50.00	Low	View details for Oppenheimer rating of Q32 Bio (NASDAQ:QTTB) on 4/11/2024
LVRO Lavoro	$5.85	4/11/2024	Initiated by	Oppenheimer	-	Outperform	$11.00	Low	View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 4/11/2024
XPO XPO	$118.88 -2.8%	4/10/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$130.00 -> $140.00	Low	View details for Oppenheimer rating of XPO (NYSE:XPO) on 4/10/2024
KMX CarMax	$68.53 -1.8%	4/9/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$105.00	Low	View details for Oppenheimer rating of CarMax (NYSE:KMX) on 4/9/2024
CUE Cue Biopharma	$1.63 +8.7%	4/9/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Cue Biopharma (NASDAQ:CUE) on 4/9/2024
EFX Equifax	$237.68 -0.4%	4/9/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$273.00 -> $291.00	Low	View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/9/2024
IONS Ionis Pharmaceuticals	$40.91 -1.5%	4/9/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$72.00 -> $75.00	Low	View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/9/2024
MSCI MSCI	$511.83 -0.3%	4/9/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$659.00 -> $648.00	Low	View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/9/2024
SEIC SEI Investments	$66.08 -0.5%	4/9/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$77.00 -> $80.00	Low	View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 4/9/2024
TRU TransUnion	$69.61 -0.2%	4/9/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$81.00 -> $90.00	Low	View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 4/9/2024
APP AppLovin	$70.90 -2.0%	4/8/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$70.00 -> $85.00	Low	View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 4/8/2024
META Meta Platforms	$494.17 -1.1%	4/8/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$525.00 -> $585.00	Low	View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/8/2024
GOOG Alphabet	$156.88 +0.6%	4/8/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$172.00 -> $185.00	Low	View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 4/8/2024
HCI HCI Group	$109.95 -1.7%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$140.00	Low	View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 4/5/2024
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad) Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring… >>Click here to find out what it is.
THG The Hanover Insurance Group	$126.67 -1.9%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$150.00	Low	View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 4/5/2024
SIGI Selective Insurance Group	$100.40 -1.5%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$120.00	Low	View details for Oppenheimer rating of Selective Insurance Group (NASDAQ:SIGI) on 4/5/2024
LULU Lululemon Athletica	$344.86 +1.7%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$540.00 -> $445.00	Low	View details for Oppenheimer rating of Lululemon Athletica (NASDAQ:LULU) on 4/5/2024
TRV Travelers Companies	$206.58 -7.4%	4/5/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Travelers Companies (NYSE:TRV) on 4/5/2024
AXP American Express	$217.62 -0.3%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform		Low	View details for Oppenheimer rating of American Express (NYSE:AXP) on 4/5/2024
ANGO AngioDynamics	$6.33 -2.8%	4/5/2024	Upgraded by	Oppenheimer	-	Market Perform -> Outperform	$12.00	Low	View details for Oppenheimer rating of AngioDynamics (NASDAQ:ANGO) on 4/5/2024
VRT Vertiv	$81.88 -0.6%	4/5/2024	Initiated by	Oppenheimer	-	Outperform	$96.00	Low	View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/5/2024
GENI Genius Sports	$5.27 +2.9%	4/4/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Genius Sports (NYSE:GENI) on 4/4/2024
ULTA Ulta Beauty	$424.55 +0.1%	4/4/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$600.00 -> $500.00	Low	View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 4/4/2024
COIN Coinbase Global	$213.78 -2.3%	4/4/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$200.00 -> $276.00	Low	View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 4/4/2024
AYI Acuity Brands	$248.47 -1.4%	4/4/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$250.00 -> $315.00	Low	View details for Oppenheimer rating of Acuity Brands (NYSE:AYI) on 4/4/2024
BMEA Biomea Fusion	$11.50 -3.8%	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$70.00	Low	View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 4/3/2024
CMCSA Comcast	$38.99 -0.3%	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$55.00	Low	View details for Oppenheimer rating of Comcast (NASDAQ:CMCSA) on 4/3/2024
STRO Sutro Biopharma	$3.80 -3.6%	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 4/3/2024
TMUS T-Mobile US	$160.09 +0.2%	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$190.00	Low	View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 4/3/2024
VZ Verizon Communications	$39.77	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$48.00	Low	View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/3/2024
ALDX Aldeyra Therapeutics	$3.97 +2.6%	4/3/2024	Upgraded by	Oppenheimer	-	Market Perform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/3/2024
AIT Applied Industrial Technologies	$184.27 -1.9%	4/2/2024	Initiated by	Oppenheimer	-	Outperform	$235.00	Low	View details for Oppenheimer rating of Applied Industrial Technologies (NYSE:AIT) on 4/2/2024
MVST Microvast	$0.52 -1.9%	4/2/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$8.00 -> $4.00	Low	View details for Oppenheimer rating of Microvast (NASDAQ:MVST) on 4/2/2024
MCO Moody's	$375.41 +1.3%	4/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$411.00 -> $424.00	Low	View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 4/2/2024
SPGI S&P Global	$412.11 +0.9%	4/2/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$480.00	Low	View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/2/2024
TSLA Tesla	$155.45 -1.1%	4/2/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/2/2024
JEF Jefferies Financial Group	$41.22 +0.4%	4/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$52.00 -> $54.00	Low	View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/2/2024
ACHV Achieve Life Sciences	$4.57 +4.3%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$18.00	Low	View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 4/1/2024
CALC CalciMedica	$4.18 -3.7%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$14.00	Low	View details for Oppenheimer rating of CalciMedica (NASDAQ:CALC) on 4/1/2024
CTAS Cintas	$668.51 +0.3%	4/1/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Cintas (NASDAQ:CTAS) on 4/1/2024
DRRX DURECT	$0.88 +12.9%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$5.00	Low	View details for Oppenheimer rating of DURECT (NASDAQ:DRRX) on 4/1/2024
KALA KALA BIO	$6.84 -0.1%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$15.00	Low	View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 4/1/2024
NCNA NuCana	$3.97 +1.8%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$100.00	Low	View details for Oppenheimer rating of NuCana (NASDAQ:NCNA) on 4/1/2024
CATX Perspective Therapeutics	1.43 -2.1%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	1.20 -> 1.50	N/A	View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 4/1/2024
RH RH	$243.73 +0.2%	4/1/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of RH (NYSE:RH) on 4/1/2024
SMTC Semtech	$32.86 -0.2%	4/1/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Semtech (NASDAQ:SMTC) on 4/1/2024
ZURA Zura Bio	$3.13 +3.0%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$17.00 -> $16.00	Low	View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 4/1/2024
SG Sweetgreen	$20.81 -1.7%	4/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$17.00 -> $34.00	Low	View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 4/1/2024
BRZE Braze	$39.53 -1.6%	3/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$75.00	Low	View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 3/28/2024
CLRB Cellectar Biosciences	$3.21 -3.0%	3/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$11.00 -> $12.00	Low	View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 3/28/2024
POOL Pool	$364.15 -1.6%	3/28/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$407.00 -> $436.00	Low	View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 3/28/2024
RUM Rumble	$6.17 +2.0%	3/28/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Rumble (NASDAQ:RUM) on 3/28/2024
SPXC SPX Technologies	$117.50 -1.1%	3/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$124.00 -> $134.00	Low	View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 3/28/2024
CXM Sprinklr	$11.36 +0.2%	3/28/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Sprinklr (NYSE:CXM) on 3/28/2024
VRNT Verint Systems	$29.13 -0.4%	3/28/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Verint Systems (NASDAQ:VRNT) on 3/28/2024
IMVT Immunovant	$28.43 -6.5%	3/28/2024	Initiated by	Oppenheimer	-	Outperform	$50.00	Low	View details for Oppenheimer rating of Immunovant (NASDAQ:IMVT) on 3/28/2024
XERS Xeris Biopharma	$1.78 -1.1%	3/28/2024	Initiated by	Oppenheimer	-	Outperform	$5.00	Low	View details for Oppenheimer rating of Xeris Biopharma (NASDAQ:XERS) on 3/28/2024
CPRX Catalyst Pharmaceuticals	$16.00 +3.0%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$29.00	Low	View details for Oppenheimer rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/27/2024
CGTX Cognition Therapeutics	$1.90 +0.5%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$9.00	Low	View details for Oppenheimer rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/27/2024
FRGE Forge Global	$1.82 +1.7%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$3.50	Low	View details for Oppenheimer rating of Forge Global (NYSE:FRGE) on 3/27/2024
PRGS Progress Software	$50.59 -0.3%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$66.00	Low	View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 3/27/2024
STRO Sutro Biopharma	$3.80 -3.6%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 3/27/2024
WPRT Westport Fuel Systems	$5.69 -0.2%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$19.00	Low	View details for Oppenheimer rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024
ADBE Adobe	$474.45 -0.4%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$660.00	Low	View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/27/2024
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad) Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring… >>Click here to find out what it is.
UPS United Parcel Service	$142.25 -0.4%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$153.00	Low	View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 3/27/2024
HCI HCI Group	$109.95 -1.7%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$140.00	Low	View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 3/27/2024
VKTX Viking Therapeutics	$66.47 -2.2%	3/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$116.00 -> $138.00	Low	View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024
ALSN Allison Transmission	$79.78 -0.6%	3/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$67.00 -> $90.00	Low	View details for Oppenheimer rating of Allison Transmission (NYSE:ALSN) on 3/26/2024
A Agilent Technologies	$134.55 -1.6%	3/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$67.00 -> $90.00	Low	View details for Oppenheimer rating of Agilent Technologies (NYSE:A) on 3/26/2024
HARP Harpoon Therapeutics	$23.01	3/26/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform		N/A	View details for Oppenheimer rating of Harpoon Therapeutics (NASDAQ:HARP) on 3/26/2024
ADUS Addus HomeCare	$96.62 -0.4%	3/26/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$118.00	Low	View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 3/26/2024
DYN Dyne Therapeutics	$24.82 +0.8%	3/26/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$47.00	Low	View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/26/2024
TH Target Hospitality	$10.64 +1.0%	3/25/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$12.00 -> $10.00	Low	View details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 3/25/2024
TSLA Tesla	$155.45 -1.1%	3/25/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 3/25/2024
AMPX Amprius Technologies	$1.72 +1.8%	3/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$15.00	Low	View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 3/22/2024
DRI Darden Restaurants	$152.97 -0.8%	3/22/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$186.00 -> $182.00	Low	View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/22/2024
FDS FactSet Research Systems	$429.25 +0.5%	3/22/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of FactSet Research Systems (NYSE:FDS) on 3/22/2024
FDX FedEx	$263.07 -0.7%	3/22/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of FedEx (NYSE:FDX) on 3/22/2024
SHAK Shake Shack	$94.93 -1.7%	3/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$108.00 -> $120.00	Low	View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 3/22/2024
ROP Roper Technologies	$526.47 -0.1%	3/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$580.00 -> $650.00	Low	View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 3/22/2024
KNF Knife River	$78.08 -0.9%	3/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$75.00 -> $85.00	Low	View details for Oppenheimer rating of Knife River (NYSE:KNF) on 3/22/2024
DMAC DiaMedica Therapeutics	$2.60 +9.7%	3/21/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$7.00 -> $6.00	Low	View details for Oppenheimer rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 3/21/2024
TKR Timken	$83.85 -1.1%	3/21/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$97.00 -> $100.00	Low	View details for Oppenheimer rating of Timken (NYSE:TKR) on 3/21/2024
TOL Toll Brothers	$113.42 -0.8%	3/21/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$141.00 -> $157.00	Low	View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 3/21/2024
TRVI Trevi Therapeutics	$2.58 -3.0%	3/21/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$9.00	Low	View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/21/2024
VOR Vor Biopharma	$1.73 +1.2%	3/21/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$17.00 -> $15.00	Low	View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 3/21/2024
DKS DICK'S Sporting Goods	$196.93 -0.9%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$190.00 -> $240.00	Low	View details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 3/20/2024
CSL Carlisle Companies	$368.76 -1.5%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$355.00 -> $405.00	Low	View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 3/20/2024
CRNX Crinetics Pharmaceuticals	$44.01 +1.2%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$54.00 -> $55.00	Low	View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/20/2024
EQIX Equinix	$734.56 -1.0%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$875.00 -> $950.00	Low	View details for Oppenheimer rating of Equinix (NASDAQ:EQIX) on 3/20/2024
NVDA NVIDIA	$840.35 -3.9%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$850.00 -> $1,100.00	Low	View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 3/20/2024
CRVS Corvus Pharmaceuticals	$1.36 -7.5%	3/20/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$8.00 -> $7.00	Low	View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/20/2024
STEP StepStone Group	$35.37 +0.1%	3/20/2024	Initiated by	Oppenheimer	-	Outperform	$48.00	Low	View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 3/20/2024
GRWG GrowGeneration	$2.14 -4.0%	3/20/2024	Downgraded by	Oppenheimer	-	Outperform -> Market Perform		Low	View details for Oppenheimer rating of GrowGeneration (NASDAQ:GRWG) on 3/20/2024
C Citigroup	$58.17 +2.0%	3/19/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$95.00 -> $88.00	Low	View details for Oppenheimer rating of Citigroup (NYSE:C) on 3/19/2024
CATX Perspective Therapeutics	1.43 -2.1%	3/19/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	1.20	N/A	View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 3/19/2024
GS The Goldman Sachs Group	$403.91 +1.8%	3/19/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$506.00 -> $446.00	Low	View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 3/19/2024
JPM JPMorgan Chase & Co.	$179.96 -0.5%	3/19/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$238.00 -> $219.00	Low	View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 3/19/2024
MS Morgan Stanley	$90.08 +1.1%	3/19/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$109.00 -> $97.00	Low	View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 3/19/2024
USB U.S. Bancorp	$39.52 -3.6%	3/19/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$61.00 -> $55.00	Low	View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 3/19/2024
WFC Wells Fargo & Company	$57.18 +1.4%	3/19/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 3/19/2024
ALPN Alpine Immune Sciences	$64.46 -0.1%	3/19/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$33.00 -> $44.00	Low	View details for Oppenheimer rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024
BAC Bank of America	$35.22 +1.6%	3/19/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$50.00 -> $46.00	Low	View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 3/19/2024
MOD Modine Manufacturing	$85.64 -5.2%	3/19/2024	Initiated by	Oppenheimer	-	Outperform	$105.00	Low	View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 3/19/2024
CRBP Corbus Pharmaceuticals	$37.16 -9.6%	3/13/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$51.00 -> $58.00	Low	View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/13/2024
CRNX Crinetics Pharmaceuticals	$44.01 +1.2%	3/13/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$48.00 -> $54.00	Low	View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/13/2024
DRI Darden Restaurants	$152.97 -0.8%	3/13/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$186.00	Low	View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/13/2024
RRX Regal Rexnord	$159.53 -2.1%	3/13/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$185.00 -> $210.00	Low	View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 3/13/2024
TRMB Trimble	$58.49 -0.7%	3/14/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$65.00 -> $72.00	Low	View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 3/14/2024
ADBE Adobe	$474.45 -0.4%	3/15/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$660.00	N/A	View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/15/2024
LEN Lennar	$151.88 -0.5%	3/15/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		N/A	View details for Oppenheimer rating of Lennar (NYSE:LEN) on 3/15/2024
MDGL Madrigal Pharmaceuticals	$228.34 -2.0%	3/15/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$320.00 -> $375.00	N/A	View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/15/2024
PTMN Portman Ridge Finance	$19.09 +0.6%	3/15/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform	$20.00	N/A	View details for Oppenheimer rating of Portman Ridge Finance (NASDAQ:PTMN) on 3/15/2024
SEIC SEI Investments	$66.08 -0.5%	3/15/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$73.00 -> $77.00	N/A	View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 3/15/2024
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad) Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring… >>Click here to find out what it is.
SMAR Smartsheet	$37.70 +3.1%	3/15/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$60.00 -> $55.00	N/A	View details for Oppenheimer rating of Smartsheet (NYSE:SMAR) on 3/15/2024
URGN UroGen Pharma	$14.24 -1.7%	3/15/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$35.00 -> $34.00	N/A	View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 3/15/2024
WSM Williams-Sonoma	$282.23 -0.1%	3/15/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		N/A	View details for Oppenheimer rating of Williams-Sonoma (NYSE:WSM) on 3/15/2024
EW Edwards Lifesciences	$87.24 -3.1%	3/18/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$93.00 -> $100.00	Low	View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 3/18/2024
WCN Waste Connections	$164.72 +0.0%	3/18/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$170.00 -> $180.00	Low	View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 3/18/2024
VTYX Ventyx Biosciences	$4.38 -8.0%	3/12/2024	Upgraded by	Oppenheimer	-	Market Perform -> Outperform	$12.00	Low	View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 3/12/2024
NFLX Netflix	$613.69 -0.6%	3/11/2024	Target Raised by	Oppenheimer	-	Outperform	$615.00 -> $725.00	Low	View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 3/11/2024
RWAY Runway Growth Finance	$12.58 +1.5%	3/8/2024	Reiterated by	Oppenheimer	-	Outperform -> Market Perform		Low	View details for Oppenheimer rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024
FIGS FIGS	$4.72 +1.3%	3/8/2024	Downgraded by	Oppenheimer	-	Outperform -> Market Perform		Low	View details for Oppenheimer rating of FIGS (NYSE:FIGS) on 3/8/2024
FROG JFrog	$38.03 +1.4%	3/7/2024	Target Raised by	Oppenheimer	-		$41.00 -> $48.00	Low	View details for Oppenheimer rating of JFrog (NASDAQ:FROG) on 3/7/2024
EHAB Enhabit	$10.16 -0.8%	3/7/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Enhabit (NYSE:EHAB) on 3/7/2024
JSPR Jasper Therapeutics	$23.82 -1.4%	3/7/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$80.00	Low	View details for Oppenheimer rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/7/2024
MRNS Marinus Pharmaceuticals	$1.44 +20.0%	3/7/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform	$9.00	Low	View details for Oppenheimer rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/7/2024
PNR Pentair	$79.15 -1.1%	3/7/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$82.00 -> $88.00	Low	View details for Oppenheimer rating of Pentair (NYSE:PNR) on 3/7/2024
RSI Rush Street Interactive	$6.33 -2.3%	3/7/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$7.00 -> $9.00	Low	View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 3/7/2024
WCC WESCO International	$152.48 -1.5%	3/7/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$175.00 -> $190.00	N/A	View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 3/7/2024
AOMR Angel Oak Mortgage REIT	$11.11 +2.3%	3/6/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 3/6/2024
CNNE Cannae	$19.43 -1.2%	3/6/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$25.00 -> $27.00	Low	View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 3/6/2024
CHPT ChargePoint	$1.40 -6.7%	3/6/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of ChargePoint (NYSE:CHPT) on 3/6/2024
BASE Couchbase	$23.83 -2.1%	3/6/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$25.00 -> $36.00	Low	View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 3/6/2024
CRWD CrowdStrike	$293.69 -1.8%	3/6/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$300.00 -> $355.00	N/A	View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024
DG Dollar General	$144.47 -0.4%	3/6/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Dollar General (NYSE:DG) on 3/6/2024
HCP HashiCorp	$23.53 -0.5%	3/6/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$34.00	Low	View details for Oppenheimer rating of HashiCorp (NASDAQ:HCP) on 3/6/2024
IONS Ionis Pharmaceuticals	$40.91 -1.5%	3/6/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$65.00 -> $72.00	Low	View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 3/6/2024
MCRB Seres Therapeutics	$0.63 -1.6%	3/6/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$9.00 -> $5.00	Low	View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024
SCM Stellus Capital Investment	$13.49	3/6/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform	$14.00	Low	View details for Oppenheimer rating of Stellus Capital Investment (NYSE:SCM) on 3/6/2024
SYF Synchrony Financial	$39.68 -0.6%	3/6/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Synchrony Financial (NYSE:SYF) on 3/6/2024
AEVA Aeva Technologies	$2.98 -6.3%	3/6/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$25.00	Low	View details for Oppenheimer rating of Aeva Technologies (NYSE:AEVA) on 3/6/2024
ETNB 89bio	$9.16 -2.2%	3/5/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of 89bio (NASDAQ:ETNB) on 3/5/2024
CODI Compass Diversified	$22.15 -1.1%	3/5/2024	Target Raised by	Oppenheimer	-	Market Perform -> Market Perform	$21.00 -> $23.00	Low	View details for Oppenheimer rating of Compass Diversified (NYSE:CODI) on 3/5/2024
COST Costco Wholesale	$715.19 -0.1%	3/5/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$760.00 -> $805.00	Low	View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 3/5/2024
DYN Dyne Therapeutics	$24.82 +0.8%	3/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$44.00 -> $47.00	Low	View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/5/2024
GE General Electric	$155.67 -0.7%	3/5/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of General Electric (NYSE:GE) on 3/5/2024
IMRX Immuneering	$1.86 +1.1%	3/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$25.00	Low	View details for Oppenheimer rating of Immuneering (NASDAQ:IMRX) on 3/5/2024
GWW W.W. Grainger	$949.92 -0.7%	3/5/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$1,075.00 -> $1,125.00	Low	View details for Oppenheimer rating of W.W. Grainger (NYSE:GWW) on 3/5/2024
AVDL Avadel Pharmaceuticals	$17.99 -0.6%	3/5/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$27.00 -> $29.00	Low	View details for Oppenheimer rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/5/2024
DLTR Dollar Tree	$123.75 -0.2%	3/4/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Dollar Tree (NASDAQ:DLTR) on 3/4/2024
CYTK Cytokinetics	$67.93 -1.6%	3/4/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$107.00	Low	View details for Oppenheimer rating of Cytokinetics (NASDAQ:CYTK) on 3/4/2024
LOW Lowe's Companies	$228.86 +0.2%	3/4/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform	$230.00	Low	View details for Oppenheimer rating of Lowe’s Companies (NYSE:LOW) on 3/4/2024
MDGL Madrigal Pharmaceuticals	$228.34 -2.0%	3/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$300.00 -> $320.00	Low	View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/1/2024
SG Sweetgreen	$20.81 -1.7%	3/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$15.00 -> $17.00	Low	View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 3/1/2024
PNTG The Pennant Group	$20.01	3/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$18.00 -> $22.00	Low	View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 3/1/2024
ADSK Autodesk	$214.92 -5.8%	3/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$265.00 -> $315.00	Low	View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 3/1/2024
AVGO Broadcom	$1,282.63 -3.5%	3/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$1,100.00 -> $1,500.00	Low	View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 3/1/2024
ESTC Elastic	$94.61 -0.6%	3/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$110.00 -> $130.00	Low	View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 3/1/2024
HRZN Horizon Technology Finance	$11.20 -0.4%	3/1/2024	Target Lowered by	Oppenheimer	-	Market Perform -> Market Perform	$11.00 -> $10.00	Low	View details for Oppenheimer rating of Horizon Technology Finance (NASDAQ:HRZN) on 3/1/2024
EVH Evolent Health	$29.65 -1.7%	3/1/2024	Initiated by	Oppenheimer	-	Outperform	$45.00	N/A	View details for Oppenheimer rating of Evolent Health (NYSE:EVH) on 3/1/2024
TBLA Taboola.com	$3.91 -0.8%	2/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$5.50 -> $6.00	Low	View details for Oppenheimer rating of Taboola.com (NASDAQ:TBLA) on 2/29/2024
CHE Chemed	$604.17 -1.0%	2/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$625.00 -> $650.00	Low	View details for Oppenheimer rating of Chemed (NYSE:CHE) on 2/29/2024
CRNX Crinetics Pharmaceuticals	$44.01 +1.2%	2/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$46.00 -> $48.00	Low	View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 2/29/2024
The “Perfect Storm” for Gold (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide!
IMCR Immunocore	$54.58 +2.3%	2/29/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$85.00 -> $87.00	Low	View details for Oppenheimer rating of Immunocore (NASDAQ:IMCR) on 2/29/2024
MRVL Marvell Technology	$66.48 -2.6%	2/29/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$70.00 -> $80.00	Low	View details for Oppenheimer rating of Marvell Technology (NASDAQ:MRVL) on 2/29/2024
MMSI Merit Medical Systems	$71.51 -1.7%	2/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$82.00 -> $87.00	Low	View details for Oppenheimer rating of Merit Medical Systems (NASDAQ:MMSI) on 2/29/2024
OKTA Okta	$93.80 -1.3%	2/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$110.00 -> $125.00	Low	View details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 2/29/2024
RLJ RLJ Lodging Trust	$10.96 -2.4%	2/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$14.00 -> $15.00	Low	View details for Oppenheimer rating of RLJ Lodging Trust (NYSE:RLJ) on 2/29/2024
RXST RxSight	$52.83 -2.7%	2/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$54.00 -> $61.00	Low	View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 2/29/2024
SHLS Shoals Technologies Group	$8.28 -0.8%	2/29/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$42.00 -> $17.00	Low	View details for Oppenheimer rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024
SNOW Snowflake	$148.80 -1.0%	2/29/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$240.00 -> $220.00	Low	View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 2/29/2024
ARVN Arvinas	$33.45 +0.0%	2/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$95.00 -> $80.00	Low	View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 2/28/2024
CLVT Clarivate	$6.91 +1.8%	2/28/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$11.00 -> $10.00	Low	View details for Oppenheimer rating of Clarivate (NYSE:CLVT) on 2/28/2024
COMP Compass	$3.34 -3.2%	2/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$5.50 -> $6.00	Low	View details for Oppenheimer rating of Compass (NYSE:COMP) on 2/28/2024
FSLR First Solar	$178.01 +2.8%	2/28/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$268.00 -> $269.00	Low	View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 2/28/2024
IAS Integral Ad Science	$9.37 -1.7%	2/28/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$25.00 -> $20.00	Low	View details for Oppenheimer rating of Integral Ad Science (NASDAQ:IAS) on 2/28/2024
QUIK QuickLogic	$12.48 -1.8%	2/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$12.00 -> $16.00	Low	View details for Oppenheimer rating of QuickLogic (NASDAQ:QUIK) on 2/28/2024
RSG Republic Services	$188.95 +0.8%	2/28/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$182.00 -> $195.00	Low	View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 2/28/2024
TARS Tarsus Pharmaceuticals	$34.42 -1.4%	2/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$55.00 -> $59.00	Low	View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/28/2024
VKTX Viking Therapeutics	$66.47 -2.2%	2/28/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$46.00 -> $116.00	Low	View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 2/28/2024
WMT Walmart	$59.65 -0.3%	2/26/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$67.00	Low	View details for Oppenheimer rating of Walmart (NYSE:WMT) on 2/26/2024
CARG CarGurus	$21.22 -1.7%	2/27/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$26.00 -> $30.00	Low	View details for Oppenheimer rating of CarGurus (NASDAQ:CARG) on 2/27/2024
DAWN Day One Biopharmaceuticals	$14.85 +1.6%	2/27/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 2/27/2024
FATE Fate Therapeutics	$5.27 -2.0%	2/27/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Fate Therapeutics (NASDAQ:FATE) on 2/27/2024
TMDX TransMedics Group	$87.86 -5.8%	2/27/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$92.00 -> $105.00	Low	View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 2/27/2024
IONS Ionis Pharmaceuticals	$40.91 -1.5%	2/26/2024	Reiterated by	Oppenheimer	-	Outperform	$63.00 -> $65.00	Low	View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 2/26/2024
MAIN Main Street Capital	$46.96 +0.4%	2/26/2024	Target Raised by	Oppenheimer	-	Market Perform -> Market Perform	$41.00 -> $43.00	Low	View details for Oppenheimer rating of Main Street Capital (NYSE:MAIN) on 2/26/2024
POOL Pool	$364.15 -1.6%	2/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$370.00 -> $407.00	Low	View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 2/26/2024
SONY Sony Group	$81.61 -1.6%	2/26/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$108.00	Low	View details for Oppenheimer rating of Sony Group (NYSE:SONY) on 2/26/2024
TGT Target	$164.47 +0.7%	2/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$160.00 -> $170.00	Low	View details for Oppenheimer rating of Target (NYSE:TGT) on 2/26/2024
NICE NICE	$230.54 -0.4%	2/23/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$225.00 -> $300.00	Low	View details for Oppenheimer rating of NICE (NASDAQ:NICE) on 2/23/2024
OLED Universal Display	$151.97 -1.3%	2/23/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$210.00 -> $200.00	Low	View details for Oppenheimer rating of Universal Display (NASDAQ:OLED) on 2/23/2024
SPXC SPX Technologies	$117.50 -1.1%	2/23/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$118.00 -> $124.00	Low	View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 2/23/2024
TOL Toll Brothers	$113.42 -0.8%	2/23/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$120.00 -> $141.00	Low	View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 2/23/2024
ACA Arcosa	$76.87 -2.7%	2/23/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$85.00 -> $90.00	Low	View details for Oppenheimer rating of Arcosa (NYSE:ACA) on 2/23/2024
ALTR Altair Engineering	$80.56 -0.7%	2/23/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$95.00 -> $100.00	Low	View details for Oppenheimer rating of Altair Engineering (NASDAQ:ALTR) on 2/23/2024
BLDR Builders FirstSource	$179.39 -1.5%	2/23/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$220.00 -> $242.00	Low	View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 2/23/2024
CCAP Crescent Capital BDC	$17.00 +0.1%	2/23/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$18.00 -> $19.00	Low	View details for Oppenheimer rating of Crescent Capital BDC (NASDAQ:CCAP) on 2/23/2024
INTU Intuit	$613.21 +0.3%	2/23/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$678.00 -> $712.00	Low	View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 2/23/2024
CYH Community Health Systems	$2.91 -0.3%	2/22/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$6.50 -> $5.50	Low	View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 2/22/2024
DOCN DigitalOcean	$33.23 -0.5%	2/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$37.00 -> $46.00	Low	View details for Oppenheimer rating of DigitalOcean (NASDAQ:DOCN) on 2/22/2024
NVDA NVIDIA	$840.35 -3.9%	2/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$850.00	Low	View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 2/22/2024
ADI Analog Devices	$189.43 -0.9%	2/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$215.00	Low	View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 2/22/2024
JACK Jack in the Box	$58.89 -3.3%	2/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$98.00	Low	View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 2/22/2024
PNST Pinstripes	$2.98 +1.7%	2/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$6.00	Low	View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 2/22/2024
CAKE Cheesecake Factory	$33.48 -2.2%	2/22/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Cheesecake Factory (NASDAQ:CAKE) on 2/22/2024
RUN Sunrun	$10.85 +5.0%	2/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$19.00	Low	View details for Oppenheimer rating of Sunrun (NASDAQ:RUN) on 2/22/2024
CNNE Cannae	$19.43 -1.2%	2/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$25.00	Low	View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 2/22/2024
ADSK Autodesk	$214.92 -5.8%	2/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$265.00	Low	View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 2/22/2024
GWRE Guidewire Software	$108.28 -0.9%	2/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$115.00 -> $130.00	Low	View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 2/22/2024
VEEV Veeva Systems	$199.18 -0.6%	2/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$225.00	Low	View details for Oppenheimer rating of Veeva Systems (NYSE:VEEV) on 2/22/2024
SKIL Skillsoft	$5.78 +6.1%	2/22/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 2/22/2024
CLH Clean Harbors	$191.78 -1.2%	2/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$178.00 -> $200.00	Low	View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 2/22/2024
DPZ Domino's Pizza	$482.14 -0.9%	2/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$470.00	Low	View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 2/22/2024
NVRO Nevro	$12.29 -3.2%	2/22/2024	Downgraded by	Oppenheimer	-	Outperform -> Market Perform		Low	View details for Oppenheimer rating of Nevro (NYSE:NVRO) on 2/22/2024
VTYX Ventyx Biosciences	$4.38 -8.0%	2/21/2024	Reiterated by	Oppenheimer	-	Market Perform		Low	View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 2/21/2024
LYV Live Nation Entertainment	$91.82 -0.4%	2/21/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$105.00 -> $115.00	Low	View details for Oppenheimer rating of Live Nation Entertainment (NYSE:LYV) on 2/21/2024
MDT Medtronic	$79.08 -0.2%	2/21/2024	Target Raised by	Oppenheimer	-	Market Perform -> Market Perform	$89.00 -> $92.00	Low	View details for Oppenheimer rating of Medtronic (NYSE:MDT) on 2/21/2024
PANW Palo Alto Networks	$277.33 +0.8%	2/21/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$310.00 -> $305.00	Low	View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 2/21/2024
TPH Tri Pointe Homes	$34.50 -1.4%	2/21/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$36.00 -> $41.00	Low	View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 2/21/2024
B Barnes Group	$33.40 -1.6%	2/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$36.00 -> $43.00	Low	View details for Oppenheimer rating of Barnes Group (NYSE:B) on 2/20/2024
DKNG DraftKings	$42.21 -6.1%	2/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$55.00 -> $60.00	Low	View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 2/20/2024
PRTA Prothena	$21.00 -1.6%	2/20/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$98.00 -> $80.00	Low	View details for Oppenheimer rating of Prothena (NASDAQ:PRTA) on 2/20/2024

MarketBeat Community Rating for Oppenheimer

Community Ranking:		3.1 out of 5 ( 3.1 of 5 stars)
Outperform Votes:		287 (Vote Outperform)
Underperform Votes:		172 (Vote Underperform)
Total Votes:		459

MarketBeat's community ratings are surveys of what our community members think about Oppenheimer and other research firms. Vote "Outperform" if you believe Oppenheimer's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Oppenheimer's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Oppenheimer Analyst Recommendations & Stock Picks (NYSE:OPY)

MarketBeat Community Rating for Oppenheimer

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info